Novo Nordisk A/S ADR (NVO) Social Stream
NOVO NORDISK A S (NVO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NOVO NORDISK A S.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $118.8 | $115 | $116.9 | $106.69 | 9.57% |
| 2022-02-09 | 4 | $118.8 | $115 | $116.9 | $106.69 | 9.57% |
| 2022-04-19 | 4 | $132.6 | $115 | $123.8 | $106.69 | 16.04% |
| 2022-04-25 | 4 | $130 | $118.8 | $124.4 | $106.69 | 16.6% |
| 2022-05-12 | 5 | $134.6 | $130 | $132.3 | $106.69 | 24% |
| 2022-06-16 | 5 | $134.6 | $130 | $132.3 | $106.69 | 24% |
| 2022-08-05 | 7 | $134.6 | $130 | $132.3 | $106.69 | 24% |
| 2022-12-03 | 8 | $134.6 | $130 | $132.3 | $106.69 | 24% |
| 2022-12-13 | 8 | $147 | $130 | $138.5 | $106.69 | 29.82% |
| 2023-02-01 | 8 | $147 | $145 | $146 | $106.69 | 36.85% |
| 2023-02-28 | 8 | $155 | $147 | $151 | $106.69 | 41.53% |
| 2023-03-01 | 8 | $174 | $155 | $164.5 | $106.69 | 54.19% |
| 2023-04-13 | 10 | $174 | $155 | $164.5 | $106.69 | 54.19% |
| 2023-05-10 | 9 | $195 | $174 | $184.5 | $106.69 | 72.93% |
| 2023-06-09 | 8 | $195 | $174 | $184.5 | $106.69 | 72.93% |
| 2023-07-18 | 6 | $195 | $174 | $184.5 | $106.69 | 72.93% |
| 2023-08-08 | 5 | $195 | $174 | $184.5 | $106.69 | 72.93% |
| 2023-08-10 | 5 | $214 | $195 | $204.5 | $106.69 | 91.68% |
| 2023-09-01 | 6 | $214 | $195 | $204.5 | $106.69 | 91.68% |
| 2023-09-12 | 6 | $233 | $195 | $214 | $106.69 | 100.58% |
| 2023-09-14 | 6 | $195 | $116 | $155.5 | $106.69 | 45.75% |
| 2023-10-03 | 8 | $116 | $97.5 | $106.75 | $106.69 | 0.06% |
| 2023-10-11 | 8 | $116 | $105 | $110.5 | $106.69 | 3.57% |
| 2023-11-06 | 10 | $125.2 | $105 | $115.1 | $106.69 | 7.88% |
| 2023-12-01 | 12 | $125.2 | $105 | $116.733 | $106.69 | 9.41% |
| 2023-12-06 | 11 | $125.2 | $115 | $120.1 | $106.69 | 12.57% |
The Trend in the Analyst Price Target
NVO's average price target has moved up $53.82 over the prior 43 months.
Over the past 45 weeks, NVO's average upside potential has been 9%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 8 | 147.0 | 145 | 146.0 | 139.08 | 4.98% |
| 2023-02-01 | 8 | 155.0 | 147 | 151.0 | 139.08 | 8.57% |
| 2023-04-13 | 9 | 174.0 | 155 | 164.5 | 167.64 | -1.87% |
| 2023-07-18 | 5 | 195.0 | 174 | 184.5 | 160.25 | 15.13% |
| 2023-11-06 | 11 | 125.2 | 105 | 115.1 | 101.08 | 13.87% |
NVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.82 | 8 | 0 | 1 | 1 | 1 | 11 |
The Trend in the Broker Recommendations
Over the past 25 months, NVO's average broker recommendation rating improved by 0.65.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVO as an investment opportunity.
- In the context of stocks in the mega market cap category, NOVO NORDISK A S's number of analysts covering the stock is greater than 193.43% of them.
- NVO has a lower variance in analysts' estimates than -243.01% of stocks in the mega market cap category.
- NVO has a greater average analyst price target than 3201.05% of Pharmaceutical Products stocks.
- NOVO NORDISK A S's upside potential (average analyst target price relative to current price) is higher than 2573.96% of stocks in the mega market cap category.
Stocks similar to NOVO NORDISK A S in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AZN, NVS, and ABBV.
View All Top Stocks by Price Target
What is the outlook for NVO? Use POWR Ratings for clearer insight into price direction.